These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2909563)
21. Relationship between ease of inducibility of arrhythmia with electrophysiologic testing and response to antiarrhythmic therapy. Amann FW; Blatt CM; Podrid PJ; Lown B Am Heart J; 1986 Apr; 111(4):625-31. PubMed ID: 3953383 [TBL] [Abstract][Full Text] [Related]
22. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507 [TBL] [Abstract][Full Text] [Related]
23. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience. Bigger JT Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278 [TBL] [Abstract][Full Text] [Related]
24. Surgery for ventricular tachycardia of left ventricular origin: risk factors for success and long-term outcome. von Oppell UO; Milne D; Okreglicki A; Scott Millar RN Eur J Cardiothorac Surg; 2002 Nov; 22(5):762-70. PubMed ID: 12414043 [TBL] [Abstract][Full Text] [Related]
25. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149 [TBL] [Abstract][Full Text] [Related]
26. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction. Kron IL; Lerman B; DiMarco JP Ann Thorac Surg; 1986 Jul; 42(1):13-6. PubMed ID: 3729611 [TBL] [Abstract][Full Text] [Related]
27. [Malignant ventricular arrhythmias in the subacute and late phases of myocardial infarction. Clinical arrhythmological characteristics and prognostic value]. Proclemer A; Facchin D; Fresco C; Bernardi G; Fontanelli A; Feruglio GA G Ital Cardiol; 1990 May; 20(5):400-11. PubMed ID: 2210161 [TBL] [Abstract][Full Text] [Related]
29. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
30. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319 [TBL] [Abstract][Full Text] [Related]
31. [Surgery for arrhythmia in patients with therapy-resistant ventricular tachycardia]. Candinas R; Welter M; Gloor HO; Amann FW; von Segesser L; Turina M Schweiz Med Wochenschr; 1993 Sep; 123(35):1631-9. PubMed ID: 8211013 [TBL] [Abstract][Full Text] [Related]
32. Reproducibility of electrophysiologic testing during antiarrhythmic therapy for ventricular arrhythmias secondary to coronary artery disease. Ferrick KJ; Luce J; Miller S; Mercando AD; Kim SG; Roth JA; Fisher JD Am J Cardiol; 1992 May; 69(16):1296-9. PubMed ID: 1585863 [TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061 [TBL] [Abstract][Full Text] [Related]
34. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. Ruskin JN; DiMarco JP; Garan H N Engl J Med; 1980 Sep; 303(11):607-13. PubMed ID: 6772952 [TBL] [Abstract][Full Text] [Related]
35. Results of revascularization in patients with severe left ventricular dysfunction. Mickleborough LL; Maruyama H; Takagi Y; Mohamed S; Sun Z; Ebisuzaki L Circulation; 1995 Nov; 92(9 Suppl):II73-9. PubMed ID: 7586465 [TBL] [Abstract][Full Text] [Related]
36. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Silka MJ; Kron J; Dunnigan A; Dick M Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901 [TBL] [Abstract][Full Text] [Related]
37. Indications for antiarrhythmic suppression of ventricular arrhythmias: a definition of life-threatening ventricular arrhythmias. Morganroth J Am J Cardiol; 1993 Aug; 72(4):3A-7A. PubMed ID: 8346724 [TBL] [Abstract][Full Text] [Related]
38. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium. Lucchesi BR Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259 [TBL] [Abstract][Full Text] [Related]
39. Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias. Lal R; Chapman PD; Naccarrelli GV; Troup PJ; Rinkenberger RL; Dougherty AH; Ruffy R J Am Coll Cardiol; 1985 Oct; 6(4):772-9. PubMed ID: 3928725 [TBL] [Abstract][Full Text] [Related]
40. Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Beaty RS; Moffett BS; Hall S; Kim J Pediatr Cardiol; 2015 Oct; 36(7):1465-9. PubMed ID: 25981562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]